Accelerating the early angiogenesis of tissue engineering constructs in vivo by the use of stem cells cultured in matrigel

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 6, 2014, Pages 1652-1662

  Schumann, Paul ^a   Lindhorst, Daniel ^a   Von See, Constantin ^a   Menzel, Nadine ^a   Kampmann, Andreas ^a   Tavassol, Frank ^a   Kokemüller, Horst ^a   Rana, Majeed ^a   Gellrich, Nils Claudius ^a   Rücker, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

dorsal skinfold chamber; intravital fluorescence microscopy; osteoblast like cells; vascularization; vitalized scaffold

Indexed keywords

BLOOD VESSELS; CELL CULTURE; DOSIMETRY; FLUORESCENCE MICROSCOPY; STEM CELLS; TISSUE;

CLINICAL APPLICATION; DORSAL SKINFOLD CHAMBERS; ENGINEERED TISSUES; MESENCHYMAL STEM CELL; MICROVASCULAR GROWTH; MICROVASCULAR NETWORK; OSTEOBLAST-LIKE CELLS; VASCULARIZATION;

SCAFFOLDS (BIOLOGY);

MATRIGEL; VASCULOTROPIN; COLLAGEN; DRUG COMBINATION; LACTIC ACID; LAMININ; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; PROTEOGLYCAN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TYPE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MESENCHYMAL STEM CELL; MICROCIRCULATION; MICROSCOPY; MOUSE; NONHUMAN; NUTRIENT SOLUTION; OSTEOBLAST; PLURIPOTENT STEM CELL; STEM CELL CULTURE; TISSUE ENGINEERING; TISSUE REACTION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; HEMODYNAMICS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MICROVASCULATURE; PROCEDURES; TISSUE SCAFFOLD; TRANSPLANTATION;

ANIMALS; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; HEMODYNAMICS; LACTIC ACID; LAMININ; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; POLYGLYCOLIC ACID; PROTEOGLYCANS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899418152     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34826     Document Type: Article

References (48)

1. Frerich B, Lindemann N, Kurtz-Hoffmann J, Oertel K,. In vitro model of a vascular stroma for the engineering of vascularized tissues. Int J Oral Maxillofac Surg 2001; 30: 414-420.
2. Krogh A,. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol 1919; 52: 409-415.
3. Awwad HK, el Naggar M, Mocktar N, Barsoum M,. Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. Int J Radiat Oncol Biol Phys 1986; 12: 1329-1333.
4. Rucker M, Laschke MW, Junker D, Carvalho C, Schramm A, Mulhaupt R, Gellrich NC, Menger MD,. Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice. Biomaterials 2006; 27: 5027-5038.
5. Schumann P, Tavassol F, Lindhorst D, Stuehmer C, Bormann KH, Kampmann A, Mulhaupt R, Laschke MW, Menger MD, Gellrich NC, Rucker M. Consequences of seeded cell type on vascularization of tissue engineering constructs in vivo. Microvasc Res 2009; 78: 180-190.
6. Laschke MW, Strohe A, Scheuer C, Eglin D, Verrier S, Alini M, Pohlemann T, Menger MD,. In vivo biocompatibility and vascularization of biodegradable porous polyurethane scaffolds for tissue engineering. Acta Biomater 2009; 5: 1991-2001.
7. Agrawal CM, Ray RB,. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 2001; 55: 141-150.
8. Druecke D, Langer S, Lamme E, Pieper J, Ugarkovic M, Steinau HU, Homann HH,. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A 2004; 68: 10-18.
9. Murphy WL, Peters MC, Kohn DH, Mooney DJ,. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2000; 21: 2521-2527.
10. Orban JM, Marra KG, Hollinger JO,. Composition options for tissue-engineered bone. Tissue Eng 2002; 8: 529-539.
11. Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, Xie XJ, Xiang MX, Zhang X,. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin 2008; 29: 74-82.
12. Laschke MW, Rucker M, Jensen G, Carvalho C, Mulhaupt R, Gellrich NC, Menger MD,. Incorporation of growth factor containing Matrigel promotes vascularization of porous PLGA scaffolds. J Biomed Mater Res A 2008; 85: 397-407.
13. Tavassol F, Schumann P, Lindhorst D, Sinikovic B, Voss A, von See C, Kampmann A, Bormann KH, Carvalho C, Mulhaupt R, Harder Y, Laschke MW, Menger MD, Gellrich NC, Rucker M. Accelerated angiogenic host tissue response to poly(L-lactide-co-glycolide) scaffolds by vitalization with osteoblast-like cells. Tissue Eng Part A 2010; 16: 2265-2279.
14. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR,. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008; 294: C675-C682.
15. Lee CM, Genetos DC, You Z, Yellowley CE,. Hypoxia regulates PGE(2) release and EP1 receptor expression in osteoblastic cells. J Cell Physiol 2007; 212: 182-188.
16. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP,. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006; 20: 1495-1497.
17. Steinbrech DS, Mehrara BJ, Saadeh PB, Chin G, Dudziak ME, Gerrets RP, Gittes GK, Longaker MT,. Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. Plast Reconstr Surg 1999; 104: 738-747.
18. Valarmathi MT, Davis JM, Yost MJ, Goodwin RL, Potts JD,. A three-dimensional model of vasculogenesis. Biomaterials 2009; 30: 1098-1112.
19. Khan M, Mohsin S, Khan SN, Riazuddin S,. Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. J Cell Mol Med 2011; 15: 1515-1527.
20. Chen J, Park HC, Addabbo F, Ni J, Pelger E, Li H, Plotkin M, Goligorsky MS,. Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int 2008; 74: 879-889.
21. Schumann P, von See C, Kampmann A, Lindhorst D, Tavassol F, Kokemuller H, Bormann KH, Gellrich NC, Rucker M,. Comparably accelerated vascularization by preincorporation of aortic fragments and mesenchymal stem cells in implanted tissue engineering constructs. J Biomed Mater Res A 2011; 97: 383-394.
22. Gerecht-Nir S, Ziskind A, Cohen S, Itskovitz-Eldor J,. Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab Invest 2003; 83: 1811-1820.
23. Ruger BM, Breuss J, Hollemann D, Yanagida G, Fischer MB, Mosberger I, Chott A, Lang I, Davis PF, Hocker P, Dettke M. Vascular morphogenesis by adult bone marrow progenitor cells in three-dimensional fibrin matrices. Differentiation 2008; 76: 772-783.
24. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Lowik CW,. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002; 143: 1545-1553.
25. Hofmann A, Ritz U, Verrier S, Eglin D, Alini M, Fuchs S, Kirkpatrick CJ, Rommens PM,. The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials 2008; 29: 4217-4226.
26. Lehr HA, Leunig M, Menger MD, Nolte D, Messmer K,. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 1993; 143: 1055-1062.
27. Carvalho C, Landers R, Hübner U, Schmelzeisen R, Mülhaupt R,. Fabrication of soft and hard biocompatible scaffolds using 3D-BioplottingTM. In:, Bártolo PJ, editor. Virtual Modeling and Rapid Manufacturing- Advanced Research in Virtual and Rapid Prototyping. London: Taylor & Francis Group; 2005. p 97-102.
28. Menger MD, Steiner D, Messmer K,. Microvascular ischemia-reperfusion injury in striated muscle: significance of «no reflow». Am J Physiol 1992; 263 (6 Pt 2): H1892-H1900.
29. Laschke MW, Harder Y, Amon M, Martin I, Farhadi J, Ring A, Torio-Padron N, Schramm R, Rucker M, Junker D, Haufel JM, Carvalho C, Heberer M, Germann G, Vollmar B, Menger MD. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006; 12: 2093-2104.
30. Kannan RY, Salacinski HJ, Sales K, Butler P, Seifalian AM,. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials 2005; 26: 1857-1875.
31. Griffith CK, Miller C, Sainson RC, Calvert JW, Jeon NL, Hughes CC, George SC,. Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 2005; 11: 257-266.
32. Davies N, Dobner S, Bezuidenhout D, Schmidt C, Beck M, Zisch AH, Zilla P,. The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 2008; 29: 3531-3538.
33. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH,. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 2007; 28: 1123-1131.
34. Chen RR, Snow JK, Palmer JP, Lin AS, Duvall CL, Guldberg RE, Mooney DJ,. Host immune competence and local ischemia affects the functionality of engineered vasculature. Microcirculation 2007; 14: 77-88.
35. Leach JK, Kaigler D, Wang Z, Krebsbach PH, Mooney DJ,. Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 2006; 27: 3249-3255.
36. Shin M, Matsuda K, Ishii O, Terai H, Kaazempur-Mofrad M, Borenstein J, Detmar M, Vacanti JP,. Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed Microdevices 2004; 6: 269-278.
37. Fidkowski C, Kaazempur-Mofrad MR, Borenstein J, Vacanti JP, Langer R, Wang Y,. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng 2005; 11: 302-309.
38. Rubenstein D, Han D, Goldgraben S, El-Gendi H, Gouma PI, Frame MD,. Bioassay chamber for angiogenesis with perfused explanted arteries and electrospun scaffolding. Microcirculation 2007; 14: 723-737.
39. Yu H, Vandevord PJ, Gong W, Wu B, Song Z, Matthew HW, Wooley PH, Yang SY,. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J Orthop Res 2008; 26: 1147-1152.
40. Sun H, Qu Z, Guo Y, Zang G, Yang B,. In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds. Biomed Eng Online 2007; 6: 41.
41. Alessandri G, Girelli M, Taccagni G, Colombo A, Nicosia R, Caruso A, Baronio M, Pagano S, Cova L, Parati E,. Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab Invest 2001; 81: 875-885.
42. Athanasopoulos AN, Schneider D, Keiper T, Alt V, Pendurthi UR, Liegibel UM, Sommer U, Nawroth PP, Kasperk C, Chavakis T,. Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J Biol Chem 2007; 282: 26746-26753.
43. Fuchs S, Ghanaati S, Orth C, Barbeck M, Kolbe M, Hofmann A, Eblenkamp M, Gomes M, Reis RL, Kirkpatrick CJ,. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 2009; 30: 526-534.
44. Santos MI, Unger RE, Sousa RA, Reis RL, Kirkpatrick CJ,. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone- starch scaffold and the in vitro development of vascularization. Biomaterials 2009; 30: 4407-4415.
45. Lindhorst D, Tavassol F, von See C, Schumann P, Laschke MW, Harder Y, Bormann KH, Essig H, Kokemuller H, Kampmann A, Voss A, Mulhaupt R, Menger MD, Gellrich NC, Rucker M. Effects of VEGF loading on scaffold-confined vascularization. J Biomed Mater Res A 2010; 95: 783-792.
46. Kagiwada H, Yashiki T, Ohshima A, Tadokoro M, Nagaya N, Ohgushi H,. Human mesenchymal stem cells as a stable source of VEGF-producing cells. J Tissue Eng Regen Med 2008; 2: 184-189.
47. Ferrara N, Davis-Smyth T,. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25.
48. Steinbrech DS, Mehrara BJ, Saadeh PB, Greenwald JA, Spector JA, Gittes GK, Longaker MT,. Hypoxia increases insulinlike growth factor gene expression in rat osteoblasts. Ann Plast Surg 2000; 44: 529-534; discussion 534-535.